Studies have shown that active fund managers routinely underperform the S&P500 index*​

Co-Diagnostics, Inc. (NASDAQ: CODX)

CODX Stock Predictions and Ratings

WSX Rating:
STRONG BUY
WSX Forecast (1yr):
376.20%
Analyst Rating:
BUY
Analyst Forecast (1yr):
400%

CODX Stock Analysis

CODX PE Ratio:

CODX PEG Ratio: Not Available

CODX Forward EPS Growth (12 month): 0.00%

CODX PS Ratio: 8

CODX PSG Ratio:

CODX Forward Revenue Growth (12 month): 400.00%

CODX Articles

No data was found